Director
Director at Keros Therapeutics, Inc., filing insider transactions between 2025-06-03 and 2026-06-15. Also reports transactions at 2 other companies.
| SEC ↗ |
| 2026-05-29 | ASND | Purchase | 200 | $222.30 | $44K | SEC ↗ |
| 2026-05-26 | ASND | Purchase | 200 | $239.37 | $48K | SEC ↗ |
| 2026-05-26 | ASND | Purchase | 200 | $236.24 | $47K | SEC ↗ |
| 2026-05-15 | IMNM | Purchase | 5,000 | $20.70 | $104K | SEC ↗ |
| 2026-05-15 | KROS | Purchase | 1,000 | $10.58 | $11K | SEC ↗ |
| 2026-04-15 | KROS | Purchase | 1,000 | $11.70 | $12K | SEC ↗ |
| 2026-03-11 | IMNM | Purchase | 1,000 | $21.55 | $22K | SEC ↗ |
| 2026-03-10 | IMNM | Purchase | 1,000 | $22.12 | $22K | SEC ↗ |
| 2026-03-09 | KROS | Purchase | 2,000 | $11.21 | $22K | SEC ↗ |
| 2025-06-03 | IMNM | Purchase | 5,000 | $9.38 | $47K | SEC ↗ |